Examples of using Preotact in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
What is Preotact?
The Preotact pen and needles are not included.
How does Preotact work?
Other information about Preotact.
What Preotact contains.
Elevated serum calcium was observed during Preotact treatment.
How is Preotact used?
Preotact should not be used in paediatric patients or young adults.
What is Preotact used for?
Preotact 100 micrograms powder and solvent for solution for injection Parathyroid hormone.
When you place the cartridge in the Preotact pen, the solvent and the powder mix.
Preotact should therefore not be used in patients with severe renal impairment see section 4.3.
Children and adolescents The safety and efficacy of Preotact in patients under 18 years have not been studied.
Preotact has been shown to significantly reduce vertebral(spine) fractures, but not hip fractures.
The recommended dose is 100 micrograms of Preotact given once daily as a subcutaneous injection(under the skin) into the abdomen tummy.
Preotact should be used with caution if you suffer from kidney stones or have had kidney stones.
The European Commission granted amarketing authorisation valid throughout the European Union for Preotact to Nycomed Danmark ApS on 24 April 2006.
The usual dose of Preotact is 100 micrograms given once a day.
Preotact can be used for up to 24 months, patients can then be treated with a bisphosphonate a medicine that reduces bone loss.
As some episodes of dizzinesshave been described in patients treated with Preotact, patients should refrain from driving or using machines until symptoms have subsided.
The effects of Preotact on bone architecture were evaluated using quantitative computed tomography(QCT) and peripheral QCT.
Effect on bone mineral density(BMD) In the pivotal study, Preotact increased BMD in the lumbar spine after 18 months treatment by 6.5% compared with -0.3% for placebo p< 0.001.
Preotact is a white powder and solvent in a cartridge, which are made up into a solution for injection using a special injection pen.
Transient elevations in parathyroid hormone levels after subcutaneous injection of Preotact stimulates new bone formation on trabecular and cortical(periosteal and/or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.
Preotact has been administered in single doses up to 5 micrograms/kg and in repeated doses of up to 3 micrograms/kg/day for 3 days and up to 2.5 micrograms/kg/day for 7 days.
The active substance in Preotact, parathyroid hormone, is identical to the human parathyroid hormone.
Preotact is contraindicated in patients• with hypersensitivity to parathyroid hormone or to any of the excipients(see section 6.1)• who have previously received radiation therapy to the skeleton• with pre-existing hypercalcemia and other disturbances in the phosphocalcic metabolism• with metabolic bone diseases other than primary osteoporosis(including hyperparathyroidism and Paget' s disease of the bone)• with unexplained elevations of bone-specific alkaline phosphatase• with severe renal impairment• with severe hepatic impairment.
If you forget to take Preotact(or cannot take Preotact at your usual time), take it as soon as possible on that day.
Treatment with Preotact reduced volumetric cortical bone BMD(measured at the distal radius and mid-shaft tibia), while periosteal circumference or indices of cortical bone strength were maintained.
A total of 2532 patients(1286 Preotact and 1246 placebo), aged 45-94 years(8.1% 45-54 years and 11.4%> 75 years), were randomised to receive 100 micrograms/day or placebo with daily calcium(700 mg) and vitamin D(400 IU) supplementation.